The study explores the role of the receptor for advanced glycation end products (RAGE) in psoriasis by comparing its expression in affected and normal skin samples from patients.
Results show that RAGE expression is significantly higher in psoriatic plaques compared to normal skin, but this elevation does not correlate with the severity of the disease.
The main limitation is that the assessment was semi-quantitative and relied on immunohistochemical detection in skin biopsies.